Latest news
Collegium Pharmaceutical (COLL) Stock Revenue Growth Masks Deepening Margin Squeeze - simplywall.stsimplywall.st · Sat, 08 Aug 2026 18:41:25 GMTCollegium Pharmaceutical (NASDAQ:COLL) Cut to "Hold" at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 05:54:41 GMTCollegium Pharmaceutical (NASDAQ:COLL) Releases Earnings Results, Beats Estimates By $0.20 EPS - MarketBeatMarketBeat · Sat, 08 Aug 2026 04:52:38 GMTPiper Sandler Maintains Collegium Pharmaceutical(COLL.US) With Hold Rating, Cuts Target Price to $43 - MoomooMoomoo · Sat, 08 Aug 2026 03:41:40 GMTCollegium Pharmaceutical, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:COLL) 2026-08-07 - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 10:31:46 GMTCollegium Pharmaceutical Inc (COLL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKeyTradingKey · Fri, 07 Aug 2026 10:02:00 GMTCOLL Q2 Deep Dive: ADHD Expansion and Pain Business Headwinds Shape Guidance - StockStoryStockStory · Fri, 07 Aug 2026 09:20:45 GMTCollegium Pharmaceutical, Inc. Q2 2026 Earnings Call Summary - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 03:27:00 GMT